Apricus wins patent allowances for NexACT technology
The NexACT technology has been used in multiple Apricus Bio products, including Vitaros, Femprox and MycoVa. The patent covers the synthesis of Dodecyl 2-(N, N-Dimethylamino)-Propionate (DDAIP), a small
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.